Nasdaq Moves to Delist GeoVax; Trading Suspension Set for Sept 8
GOVX is trading near its 52-week low of $0.59 (4.1% above the low).
Summary
Nasdaq issued a Staff Determination Letter to delist GeoVax after the stock traded below $1.00 for 30 consecutive days. The company will request a hearing before the September 3 deadline, which stays the suspension pending appeal.
Key Events · Legal and Risk Events · GOVX
-
Nasdaq Determines to Delist
Staff Determination Letter received August 27, 2026, after the bid price remained below $1.00 for 30 consecutive business days (July 16 – August 26, 2026).
-
No Grace Period Due to Reverse Split
The January 12, 2026 1-for-25 reverse split disqualifies the company from the customary 180-day compliance period under Nasdaq Rule 5810(c)(3)(A)(iv).
-
Trading Suspension Expected Sept 8
Absent a timely hearing request, trading is expected to be suspended at the opening of business on September 8, 2026.
-
Hearing Request Planned by Sept 3
The company plans to request a hearing before the September 3, 2026 deadline, which will stay further actions and keep the stock trading during the appeal.
Analysis · GOVX · Life Sciences
Nasdaq has formally determined to delist GeoVax's common stock after the bid price stayed below $1.00 for 30 straight business days. Because the company did a 1-for-25 reverse split in January, it is not eligible for the usual 180-day grace period. Trading is expected to be suspended on September 8 unless the company wins a hearing. This is a critical escalation from the July 10 equity-rule notice — the stock now faces imminent removal from a major exchange, which would severely reduce liquidity and institutional access.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GOVX was trading at $0.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.59 to $19.21. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.